Dirk Kienle

2.4k total citations
37 papers, 1.7k citations indexed

About

Dirk Kienle is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Dirk Kienle has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 20 papers in Pathology and Forensic Medicine and 14 papers in Immunology. Recurrent topics in Dirk Kienle's work include Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (18 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Dirk Kienle is often cited by papers focused on Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (18 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Dirk Kienle collaborates with scholars based in Germany, United Kingdom and Switzerland. Dirk Kienle's co-authors include Stephan Stilgenbauer, Hartmut Döhner, Alexander Kröber, Peter Lichter, Dirk Winkler, Andreas Bühler, Axel Benner, Daniel Mertens, Elke Leupolt and Thorsten Zenz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Dirk Kienle

35 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Kienle Germany 24 1.0k 807 630 492 358 37 1.7k
Evelyne Callet‐Bauchu France 26 1.1k 1.1× 1.8k 2.2× 542 0.9× 406 0.8× 906 2.5× 62 2.6k
R. D. Gascoyne Canada 24 599 0.6× 925 1.1× 535 0.8× 389 0.8× 684 1.9× 39 1.9k
Eugenia Haralambieva Germany 24 533 0.5× 1.3k 1.6× 637 1.0× 370 0.8× 883 2.5× 52 2.1k
Clara Deambrogi Italy 14 815 0.8× 847 1.0× 230 0.4× 322 0.7× 431 1.2× 35 1.3k
Ellen Schlette United States 28 1.3k 1.3× 1.3k 1.6× 701 1.1× 632 1.3× 700 2.0× 69 2.3k
Diane C. Louie United States 19 666 0.7× 1.4k 1.8× 398 0.6× 330 0.7× 944 2.6× 24 2.0k
Riccardo Bomben Italy 23 1.1k 1.0× 755 0.9× 478 0.8× 628 1.3× 285 0.8× 72 1.6k
Andreas Bühler Germany 21 2.2k 2.1× 1.6k 2.0× 599 1.0× 920 1.9× 520 1.5× 47 2.7k
Mats Merup Sweden 24 1.1k 1.1× 969 1.2× 739 1.2× 658 1.3× 632 1.8× 59 2.2k
Itziar Salaverría Spain 33 849 0.8× 1.8k 2.2× 657 1.0× 259 0.5× 1.2k 3.4× 58 2.5k

Countries citing papers authored by Dirk Kienle

Since Specialization
Citations

This map shows the geographic impact of Dirk Kienle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Kienle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Kienle more than expected).

Fields of papers citing papers by Dirk Kienle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Kienle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Kienle. The network helps show where Dirk Kienle may publish in the future.

Co-authorship network of co-authors of Dirk Kienle

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Kienle. A scholar is included among the top collaborators of Dirk Kienle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Kienle. Dirk Kienle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Went, Philip, et al.. (2020). Profound and durable responses with PD-1 immune checkpoint inhibitors in patients with metastatic penile squamous cell carcinoma. SHILAP Revista de lepidopterología. 3. 100045–100045. 3 indexed citations
2.
3.
4.
Jebaraj, Billy Michael Chelliah, Dirk Kienle, Andreas Bühler, et al.. (2012). BRAFmutations in chronic lymphocytic leukemia. Leukemia & lymphoma. 54(6). 1177–1182. 41 indexed citations
5.
Stoeckle, Christina, et al.. (2012). Hypereosinophilia driven by GM-CSF in large-cell carcinoma of the lung. Lung Cancer. 76(3). 493–495. 29 indexed citations
6.
Kienle, Dirk, Axel Benner, Dirk Winkler, et al.. (2009). Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia. Haematologica. 95(1). 102–109. 24 indexed citations
7.
Katzenberger, Tiemo, Dirk Kienle, Stephan Stilgenbauer, et al.. (2008). Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis. British Journal of Haematology. 142(4). 538–550. 28 indexed citations
8.
Sander, Sandrine, Lars Bullinger, Elke Leupolt, et al.. (2008). Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations. Haematologica. 93(5). 680–687. 33 indexed citations
9.
Kainz, Birgit, Medhat Shehata, Martin Bilban, et al.. (2007). Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemia. International Journal of Cancer. 121(9). 1984–1993. 55 indexed citations
10.
Stilgenbauer, Stephan, Sandrine Sander, Lars Bullinger, et al.. (2007). Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival. Haematologica. 92(9). 1242–1245. 153 indexed citations
11.
Stilgenbauer, Stephan, Sandrine Sander, Lars Bullinger, et al.. (2006). Clonal Evolution in Chronic Lymphocytic Leukemia: Acquisition of High-Risk Genomic Aberrations Associated with Unmutated VH, Resistance to Therapy, and Short Survival.. Blood. 108(11). 296–296. 10 indexed citations
12.
Kröber, Alexander, Johannes Bloehdorn, Sebastian Häfner, et al.. (2006). Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and VH Mutation Status in Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 24(6). 969–975. 134 indexed citations
13.
Stilgenbauer, S., Alexander Kröber, Dirk Winkler, et al.. (2005). Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG). mediaTUM (Technical University of Munich). 18 indexed citations
14.
Heintel, Daniel, Dirk Kienle, Medhat Shehata, et al.. (2005). High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia. Leukemia. 19(7). 1216–1223. 116 indexed citations
15.
16.
Kröber, Alexander, Dirk Kienle, Dirk Winkler, et al.. (2004). ZAP-70 Expression, VH-Mutation Status, Genomic Aberrations and Prognosis in Chronic Lymphocytic Leukemia.. Blood. 104(11). 1920–1920. 2 indexed citations
17.
Kohlhammer, Holger, Carsten Schwäenen, Swen Weßendorf, et al.. (2004). Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood. 104(3). 795–801. 96 indexed citations
18.
Weßendorf, Swen, Carsten Schwäenen, Holger Kohlhammer, et al.. (2003). Hidden gene amplifications in aggressive B-cell non-Hodgkin lymphomas detected by microarray-based comparative genomic hybridization. Oncogene. 22(9). 1425–1429. 79 indexed citations
19.
Solovei, Irina, Dirk Kienle, Graham Little, et al.. (2000). Topology of double minutes (dmins) and homogeneously staining regions (HSRs) in nuclei of human neuroblastoma cell lines. Genes Chromosomes and Cancer. 29(4). 297–308. 24 indexed citations
20.
Dietzel, Steffen, Anna Jauch, Dirk Kienle, et al.. (1998). Separate and variably shaped chromosome arm domains are disclosed by chromosome arm painting in human cell nuclei. Chromosome Research. 6(1). 25–33. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelyne Callet‐Bauchu Breakdown of academic impact, for papers by R. D. Gascoyne Breakdown of academic impact, for papers by Eugenia Haralambieva Breakdown of academic impact, for papers by Clara Deambrogi Breakdown of academic impact, for papers by Ellen Schlette Breakdown of academic impact, for papers by Diane C. Louie Breakdown of academic impact, for papers by Riccardo Bomben Breakdown of academic impact, for papers by Andreas Bühler Breakdown of academic impact, for papers by Mats Merup Breakdown of academic impact, for papers by Itziar Salaverría
Rankless by CCL
2026